申请人:Alkharfy Khalid M.
公开号:US20100273893A1
公开(公告)日:2010-10-28
The present invention refers to thymoquinone, a main constituent of the volatile oil of
Nigella sativa
, and its protective effect against sepsis syndrome morbidity, mortality and associated organ dysfunctions. In particular, the present invention refers to thymoquinone for use in the prevention and/or treatment of sepsis syndrome. The present invention further refers to a pharmaceutical composition and a kit.